Author Guidelines
Editorial Board
About Us
Contact Us
Advertise
Subscribe
Issue Archive
Home
CME
CME Articles
CME Posttests
myCME
CME From AAPA
Departments
A Day in the Life
Ask a Librarian!
Case of the Month
Clinical Watch
Commentary
Critically Appraised Topic
Dermatology Digest
Diagnostic Imaging Review
Editorial
Emergency Medicine Notes
From the Academy
Genomics in PA Practice
Humane Medicine
Inside the AAPA Policy Manual
Interpreting ECGs
Letters
PA Quandaries
Pharmacology Consult
Quick Recertification Series
Sounding Board
The Surgical Patient
Topics in Infectious Diseases
What's New
When the Patient Asks
Women’s Health
Articles
AAPA Special Article
Case Reports
CME Articles
Review Articles
Surgical Reviews
The Surgical Patient
Research
Brief Report
Research Corner
Research Report
Current Issue
Current Articles
Digital Issue
Archive
Blogs
Atrial Kick: Cardiothoracic Surgery Perspectives
Health Disparities Blog
HIT Blog
Musings: The JAAPA Editorial Board Blog
Authors
Roadmap to Better Writing
Writing for Publication Webcasts
JAAPA Submission Guidelines
News
Drug Information
Medical News
Conference Coverage
Newsletters
AAPA Publications
Tools & Links
The Art of Medicine
Become a peer reviewer
Clinical Practice Guidelines
Complementary and Alternative Medicine
Drug Information
Evidence-Based Medicine
Genetics in Medicine
Medical Calculators
Online Textbooks
PA Profession
Pain
Patient Information
Substance Abuse
Videos
AAPA
AAPA Home
CME Calendar
CME Posttests
The PA Job Link
Annual Conference
Join AAPA
PA Census and Data
PA Competencies
AAPA Publications
Commentary
Online Only
PAPR Drug Information
Meetings & Conferences
Newsletters
Jobs
RSS
|
Login
|
Register
Controlled Substances
Reduced lung function and bullae resulting from illicit drug use
Amy L. Jay, PA-C July 25, 2011
A male patient was transferred for evaluation of large left bullae at risk for rupture. CT and history confirmed an interesting cause for the air pockets: marijuana, tobacco, and cocaine use.
Correction: PAs CAN prescribe buprenorphine
Keir Todd, PA-C, M.Ed. June 15, 2011
Current options in the management of opioid dependence: a review
Buprenorphine: A more accessible treatment for opioid dependence
Jason Flassing, MMSc, PA-C
September 10, 2010
Buprenorphine-naloxone holds the key to opening primary care clinics to a greater number of patients suffering from opioid addiction.
Pain management: Opioid use in chronic noncancer pain
From CSAC, the Clinical and Scientific Affairs Council of the AAPA March 11, 2010
Concerns about prescribing controlled substances and the potential for addiction should not prevent PAs from adequately managing chronic noncancer pain.
From the AAPA - November 2008
November 01, 2008
AAPA objects to proposed HHS "conscience" rule; AARP coalition seeks health care affordability; DEA drafts e-prescribing rule for controlled substances
Sponsored Links